Tadalafil Tablets USP 20 mg ALACRITY ® 20 is used to treat male sexual function problems (impotence or erectile dysfunction-ED). In combination with sexual stimulation, It works by increasing blood flow to the penis to help a man get and keep an erection.
Tadalafil Tablets USP 20 mg ALACRITY ® 20 is also used to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night).
Tadalafil Tablets USP 20 mg ALACRITY ® 20 is thought to work by relaxing the smooth muscle in the prostate and bladder.
This drug does not protect against sexually transmitted diseases (such as HIV, hepatitis B, gonorrhoea, syphilis). Practice "safe sex" such as using latex condoms. Consult your doctor or pharmacist for more details.
Tadalafil Tablets USP 20 mg ALACRITY ® 20 comes in Blister of 4 Tablets and packed in a mono cartoon with Product Insert.
|Name of the Product||GTIN - 14|
|ALACRITY ® 20||
Read the Patient Information Leaflet provided in the box supplied with ALACRITY ® before you start taking tadalafil and each time you get a refill. If you have any questions, ask your doctor or pharmacist.
Take this medication by mouth, with or without food, as directed by your doctor. Do not take tadalafil more often than once daily.
The dosage is based on your medical condition, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, non-prescription drugs, and herbal products).
To treat the symptoms of BPH, take this medication as directed by your doctor, usually once a day. If you are also taking finasteride with this medication to treat symptoms of BPH, talk with your doctor about how long you should continue taking this medication.
To treat erectile dysfunction-ED, there are 2 ways that tadalafil may be prescribed. Your doctor will determine which the best way for you to take tadalafil is. Follow your doctor's directions exactly since your dosage depends on how you are taking it. The first way is to take it as needed, usually at least 30 minutes before sexual activity. Tadalafil's effect on sexual ability may last up to 36 hours.
The second way to treat ED is to take tadalafil regularly, once a day every day. If you take it this way, you may attempt sexual activity at any time between your doses.
If you are taking tadalafil to treat both ED and BPH, take it as directed by your doctor, usually once a day. You may attempt sexual activity at any time between your doses.
If you are taking tadalafil once daily for BPH, or for ED, or for both, take it regularly to get the most benefit from it. To help you remember, take it at the same time each day.
Tell your doctor if your condition does not improve or if it worsens.
Peak plasma concentrations of Alacrity® are reached within 30 minutes to six hours (average time two hours) of a dose. Effects of 'as needed' Cialis last for up to 36 hours.
The duration of action of ALACRITY° 20 mg - tadalafil is longer than that of sildenafil or vardenafil and the effect is felt up to 36 Hours
Thus it is called WEEKLY PILL
In general, few side effects occur Tadalafil Tablets USP 20 mg ALACRITY ® 20 unless it is taken in conjunction with other drugs.
When combined with α1-adrenergic blockers such as doxazosin (Cardura), prazosin (Minipress), and terazosin (Hytrin) but not tamsulosin (Flomax)— Tadalafil Tablets USP 20 mg ALACRITY ® 20 can cause a significant drop in blood pressure.
Similarly, concomitant use of nitrates (including recreational nitrates known as “poppers”) with Tadalafil Tablets USP 20 mg ALACRITY ® 20 also is contraindicated.
For life-threatening situations, nitrates may be considered if at least 48 hours have passed since the last dose )— Tadalafil Tablets USP 20 mg ALACRITY ® 20 and if close hemodynamic monitoring is available. )— Tadalafil Tablets USP 20 mg ALACRITY ® 20 will lower blood pressure an additional 4 to 10 mm Hg when used with antihypertensive drugs. Dosage should be limited to 10 mg within a 72-hour period when patients are also taking drugs such as erythromycin, ketoconazole (Nizoral), itraconazole (Sporanox), protease inhibitors, and other drugs that inhibit the CYP3A4 enzyme system
Please do not take this drug for the following people. Nitric acid drugs
with a history of hypersensitivity to the ingredients of this drug, or medications such as those with cardiovascular disorders such as nitric oxide (NO) donor (nitroglycerin, amyl nitrite, isosorbide nitrate etc) being administered The person with severe liver dysfunction One with hypotension (blood pressure <90/50 mmHg) or one with hypertension who is not controlled by treatment (systolic blood pressure at rest> 170 mm Hg or resting diastole at rest Blood pressure> 100 mHg)
Personal history of cerebral infarction / cerebral haemorrhage or myocardial infarction is within 6 months.
Persons suffering from retinitis pigmentosa during administration of amiodarone hydrochloride (oral preparation) soluble guanylate cyclase (sGC) stimulant (Rio Siguato)
The most common dose-related side effects of tadalafil are headache (11 to 15 percent) and dyspepsia (8 to 10 percent).
Back pain, beginning 12 to 24 hours after the dose and lasting for up to 48 hours, was reported in 5 to 6 percent of men, as compared with a rate of 3 percent in men receiving placebo.
Changes in color vision, which has been reported with sildenafil, has been reported in less than 0.1 percent of patients in clinical trials of ALACRITY° 20- Tadalafil.
Tadalafil Tablets USP 20 mg ALACRITY ® 20 differs from sildenafil in its affinity for PDE6 and 11, which may account for fewer reported ocular effects and more reports of back pain with tadalafil than with sildenafil.
The main outcomes studied in the treatment of ED are achievement of an erection, successful intercourse, and overall satisfaction with sexual function. In five studies evaluating tadalafil in 5-, 10-, and 20-mg doses versus placebo, 321 men were assigned to a 10-mg regimen.
In this group, 68 to 77 percent of men reported an erection suitable for insertion, compared with 42 to 55 percent receiving placebo (number needed to treat [NNT]=4 to 4.5).
However, slightly fewer men reported successful intercourse (51 to 70 percent, NNT=4 to 5).1,5 The satisfaction with intercourse was 9.3 out of a maximum score of 15, compared with a score of 7.4 in patients taking placebo, and overall satisfaction was 6.7 out of a possible 10 with tadalafil compared with 5.2 in patients taking placebo.5
As with the other drugs in this class, overall effectiveness is diminished in patients with diabetes or ED.
Tadalafil has not been studied in patients with antidepressant-induced ED. No studies have directly compared tadalafil with sildenafil or vardenafil, but overall success rates have been comparable among the three options.